Clinical observation on zoledronic acid in treatment of the pain of metastatic bone cancer
- VernacularTitle:唑来膦酸治疗恶性肿瘤骨转移疼痛临床观察
- Author:
Peiyao YU
;
Min ZHANG
;
Qingshan ZHU
;
Jiwei LIU
- Publication Type:Journal Article
- Keywords:
Zoledronic acid;
Pamidronate disodium;
Metastatic bone cancer;
Pain
- From:
Chinese Journal of Postgraduates of Medicine
2006;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05 ) .In group A and group B ,the mean time to pain relief was (3.46?2.66) days and (4.35?1.83) days respectively , and the mean duration of the pain relief was (28.4?2.35) days and ( 15.6 ?3.85) days respectively , with no significant difference between the two groups (P0.05). Conclusions Zoledronic acid has a perfect therapeutic effect for the bone pain caused by metastatic bone cancer, with long duration of the pain relief and mild side effects. Zoledronic acid is an effcctive drug for metastatic bone cancer.
